Cited by 1,007Schizophrenia research and treatmentPsychometric Methodologies and TestingPsychological Testing and Assessment

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Kay, Stanley R., Opler, Lewis A., Lindenmayer, Jean-Pierre·1988·Psychiatry Research

DOI 10.1016/0165-1781(88)90038-8

Open this paper in CoChat — free account

Abstract

The Positive and Negative Syndrome Scale (PANSS) was developed out of the need for a well-operationalized method of assessing these syndromes in schizophrenia, including their relationship to one another and to global psychopathology. We surveyed 82 acute and chronic schizophrenics to analyze the psychometric properties of the four PANSS scales. The interrater reliabilities were in the 0.80's, and significant correlations emerged with corresponding criterion measures. The PANSS positive and negative scales were inversely intercorrelated once their shared association with general psychopathology had been partialed out. The results support the scales' reliability, criterion-related validity, and construct validity, while cross-validating some of our previous findings.

Integrity signals

Registry

Crossref · 10.1016/0165-1781(88)90038-8

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Untitled work
(1976) · Medical Entomology and Zoology · Cited by 8,899
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Negative v Positive Schizophrenia
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,008
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine
Crow, T. J. (1980) · The British Journal of Psychiatry · doi:10.1192/s0007125000071919 · Cited by 563
Treatment of Negative Symptoms
Carpenter, W. T., Heinrichs, D. W., & Alphs, L. D. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.440 · Cited by 508
Symptomatic and Neuropsychological Components of Defect States
Bilder, R. M., Mukherjee, S., Rieder, R. O., & Pandurangi, A. K. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.409 · Cited by 504
Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia
Angrist, B., Rotrosen, J., & Gershon, S. (1980) · Psychopharmacology · doi:10.1007/bf00433802 · Cited by 344
Positive and negative symptoms in schizophrenia
Rosen, W. G., Mohs, R. C., Johns, C. A., Small, N. S., Kendler, K. S., Horvath, T., & Davis, K. L. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90075-1 · Cited by 238

Show all 28 references

Research works printed but not linked: 1

Kay, 1981, Arousal in schizophrenia: Toward a dual-process model and framework for research, JSAS Catalog of Selected Documents in Psychology, 11, 35

Sorted by citations

Items 301–400 of 998

Shame and the psychosis continuum: A systematic review of the literature
Carden, L. J., Saini, P., Seddon, C., Watkins, M., & Taylor, P. J. (2018) · Psychology and Psychotherapy Theory Research and Practice · doi:10.1111/papt.12204 · Cited by 45
Akathisia and Suicidal Ideation in First-Episode Schizophrenia
Seemüller, F., Schennach, R., Mayr, A. J., Musil, R., Jäger, M., Maier, W., Klingenberg, S., Heuser, I., Klosterkötter, J., Gastpar, M., et al. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182677958 · Cited by 37
Visual Hallucinations in First-Episode Psychosis: Association with Childhood Trauma
Solesvik, M., Joa, I., Larsen, T. K., Langeveld, J., Johannessen, J. O., Bjørnestad, J. R., Anda, L. G., Gisselgård, J., Hegelstad, W. T. V., & Brønnick, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153458 · Cited by 38
Training patients with schizophrenia with the community re-entry module
Xiang, Y., Weng, Y., Li, W., Gao, L., Chen, G.-L., Xie, L., Chang, Y.-L., Tang, W. K., & Ungvari, G. S. (2006) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-006-0050-6 · Cited by 36
Pramipexole as adjunct to haloperidol in schizophrenia
Kasper, S. F., Barnas, C., Heiden, A. M., Volz, H., Laakmann, G., Zeit, H., & Pfolz, H. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00393-8 · Cited by 36
Olanzapine for Schizophrenia Refractory to Typical and Atypical Antipsychotics: An Open-Label, Prospective Trial
Lindenmayer, J., Volavka, J., Lieberman, J. A., Sheitman, B., Citrome, L., Chakos, M., Czobor, P., Parker, B., & Iskander, A. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00014 · Cited by 36
Relationship between depressive and positive symptoms in schizophrenia
Dollfus, S., Petit, M., & Ménard, J.-F. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90078-x · Cited by 36
Intolerance of uncertainty and distress associated with the experience of psychosis.
White, R. S., & Gumley, A. (2010) · Psychology and psychotherapy · doi:10.1348/147608309x477572 · Cited by 34
Gender aspects of parents’ needs of schizophrenia patients
Wancata, J., Freidl, M., Krautgartner, M., Friedrich, F., Matschnig, T., Unger, A., Gößler, R., & Frühwald, S. (2008) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-008-0391-4 · Cited by 35
WCST performance and schizotypal features in the first-degree relatives of patients with schizophrenia
Laurent, A., Duly, D., Murry, P., Foussard, N., Boccara, S., Mingat, F., Jean Dalery, A., & d’Amato, T. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00306-7 · Cited by 35
A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis
Corvin, A. P., Donohoe, G. J., Nangle, J. M., Schwaiger, S., Morris, D. W., & Gill, M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.11.031 · Cited by 35
Procedural Learning in Schizophrenia Can Reflect the Pharmacologic Properties of the Antipsychotic Treatments
Scherer, H., Bédard, M., Stip, É., Paquet, F., Richer, F., Bériault, M., Rodriguez, J.-P., & Mottard, J. (2004) · Cognitive and Behavioral Neurology · doi:10.1097/00146965-200403000-00004 · Cited by 35
Assessing positive and negative symptoms in children and adolescents
FIELDS, J. H., Grochowski, S., Lindenmayer, J., Kay, S. R., Grosz, D. E., Hyman, R. B., & Alexander, G. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.2.249 · Cited by 35
A placebo-controlled trial of selegiline (l-deprenyl) in the treatment of tardive dyskinesia
GOFF, D. C., Renshaw, P. F., Sarid‐Segal, O., Dreyfuss, D. A., AMICO, E. T., & Ciraulo, D. A. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90119-x · Cited by 35
Co-morbid PTSD and suicidality in individuals with schizophrenia and substance and alcohol abuse
Tarrier, N., & Picken, A. (2011) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0277-0 · Cited by 33
Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: The POSITIVE Study, a multicenter, prospective, single-blind, randomised controlled clinical trial
Klingberg, S., Wittorf, A., Meisner, C., Wölwer, W., Wiedemann, G., Herrlich, J., Bechdolf, A., Müller, B. W., Sartory, G., Wagner, M., et al. (2010) · Trials · doi:10.1186/1745-6215-11-123 · Cited by 34
Spousal Caregiver Burden and Its Relation with Disability in Schizophrenia
Arun, R., Inbakamal, S., Tharyan, A., & Premkumar, P. S. (2018) · Indian Journal of Psychological Medicine · doi:10.4103/ijpsym.ijpsym_204_17 · Cited by 34
A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia
DeMartinis, N. A., Lopez, R. N., Pickering, E. H., Schmidt, C. J., Gertsik, L., Walling, D. P., & Ogden, A. G. (2019) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001047 · Cited by 34
Manganese superoxide dismutase (MnSOD: Ala–9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia
Pae, C., Kim, T., Patkar, A. A., Kim, J.-J., Lee, C., Lee, S.-J., Jun, T., Lee, C., & Paik, I. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.04.011 · Cited by 34
Eleven‐year clinical outcome of schizophrenia in Bali
Kurihara, T., Kato, M., Reverger, R., & Tirta, I. G. R. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00604.x · Cited by 34
The Penn Conditional Exclusion Test (PCET): relationship to the Wisconsin Card Sorting Test and work function in patients with schizophrenia
Kurtz, M. J. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00179-8 · Cited by 34
Insight in schizophrenia–course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder
Schennach, R., Meyer, S., Seemüller, F., Jäger, M., Schmauss, M., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L. G., Gaebel, W., et al. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2012.01.001 · Cited by 32
The impact of an empowerment intervention on people with schizophrenia: Results of a randomized controlled trial
Hasan, A., & Musleh, M. (2017) · International Journal of Social Psychiatry · doi:10.1177/0020764017693652 · Cited by 33
Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?
Suttajit, S., Arunpongpaisal, S., Srisurapanont, M., Thavichachart, N., Kongsakon, R., Chantakarn, S., Chantarasak, V., Jariyavilas, A., Jaroensook, P., Kittiwattanagul, K., et al. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s88085 · Cited by 33
Schizophrenia: Measurements of Psychopathology
Lindenmayer, J., Harvey, P. D., Khan, A., & Kirkpatrick, B. W. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.04.005 · Cited by 33
Estimating transformations for repeated measures modeling of continuous bounded outcome data
Hutmacher, M. M., French, J. L., Krishnaswami, S., & Menon, S. S. (2011) · Statistics in Medicine · doi:10.1002/sim.4155 · Cited by 33
Response trajectories in “real-world” naturalistically treated schizophrenia patients
Schennach, R., Meyer, S., Seemüller, F., Jäger, M., Schmauß, M., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L., Gäebel, W., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.05.004 · Cited by 33
Cognitive adaptation training combined with assertive community treatment: A randomised longitudinal trial
Hansen, J. P., Østergaard, B., Nordentoft, M., & Hounsgaard, L. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2011.12.014 · Cited by 33
Effects of a new slow release formulation of caffeine on EEG, psychomotor and cognitive functions in sleep-deprived subjects
Patat, A. A., Rosenzweig, P., Enslen, M., Trocherie, S., Miget, N., Bozon, M., Allain, H., & Gandon, J. (2000) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(200004)15:3 · Cited by 86
Impaired sensorimotor gating in schizophrenia with deficit and with nondeficit syndrome
Ludewig, K., & Vollenweider, F. X. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.09873 · Cited by 33
Depersonalization as a Mediator in the Relationship Between Self-Focused Attention and Auditory Hallucinations
Perona-Garcelán, S., Carrascoso-López, F., García-Montes, J. M., Vallina-Fernández, O., Pérez-Álvarez, M., Ductor-Recuerda, M. J., Salas-Azcona, R., Cuevas-Yust, C., & Gómez-Gómez, M. T. (2011) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2011.602181 · Cited by 32
Is Symptomatic Improvement in Clinical Trials of Cognitive-Behavioral Therapy for Psychosis Clinically Significant?
Gaudiano, B. A. (2006) · Journal of Psychiatric Practice · doi:10.1097/00131746-200601000-00003 · Cited by 33
Effects of cognitive remediation on neurocognitive functions and psychiatric symptoms in schizophrenia inpatients
Gharaeipour, M., & Scott, B. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.09.018 · Cited by 32
Hippocampal novelty activations in schizophrenia: disease and medication effects.
Tamminga, C., Thomas, B. P., Chin, R., Mihalakos, P., Youens, K., Wagner, A., & Preston, A. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.03.019 · Cited by 32
Transition to Psychosis: 6-Month follow-up of a Chinese High-Risk Group in Hong Kong
Lam, M., Hung, S. F., & Chen, E. (2006) · Australian and New Zealand journal of psychiatry (Print) · doi:10.1080/j.1440-1614.2006.01817.x · Cited by 35
Neurological soft signs in schizophrenia: Are they related to negative or positive symptoms, neuropsychological performance, and violence?
Braun, C., Lapierre, D., Hodgins, S., Toupin, J., LEVEILLE, S., & Constantineau, C. (1995) · Archives of Clinical Neuropsychology · doi:10.1016/0887-6177(94)00050-z · Cited by 32
Dissociation and mindfulness in patients with auditory verbal hallucinations
Escudero-Pérez, S., León-Palacios, M. G., Úbeda-Gómez, J., Barros-Albarrán, M. D., López-Jiménez, A. M., & Perona-Garcelán, S. (2016) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2015.1085480 · Cited by 31
Spatial localization deficits and auditory cortical dysfunction in schizophrenia
Perrin, M. A., Butler, P. D., DiCostanzo, J., Forchelli, G. A., Silipo, G. S., & Javitt, D. C. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.06.004 · Cited by 31
Prediction of individual responses to electroconvulsive therapy in patients with schizophrenia: Machine learning analysis of resting-state electroencephalography
Min, B., Kim, M., Lee, J., Byun, J., Chu, K., Jung, K., Lee, S. K., & Kwon, J. S. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.12.012 · Cited by 31
Plasma homocysteine levels in depression and schizophrenia in South Indian Tamilian population
Narayan, S. K., Verman, A., Kattimani, S., Ananthanarayanan, P., & Adithan, C. (2014) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.124746 · Cited by 31
Is There a Gender Difference in a Factorial Structure of the Positive and Negative Syndrome Scale?
Hayashi, N., Igarashi, Y., Yamashina, M., & Suda, K. (2002) · Psychopathology · doi:10.1159/000056213 · Cited by 31
Heat shock protein 70 gene polymorphisms are associated with paranoid schizophrenia in the Polish population
Kowalczyk, M., Owczarek, A. J., Suchanek-Raif, R., Paul-Samojedny, M., Fila-Daniłow, A., Borkowska, P., Kucia, K. A., & Kowalski, J. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0446-7 · Cited by 31
Quality of life and illness beliefs in individuals with early psychosis
Theodore, K., Johnson, S., Chalmers-Brown, A., Doherty, R., Harrop, C. E., & Ellett, L. (2011) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-011-0360-1 · Cited by 31
Randomized controlled trial of computer-based treatment of social cognition in schizophrenia: the TRuSST trial protocol
Rose, A., Vinogradov, S., Fisher, M., Green, M. F., Ventura, J., Hooker, C. I., Merzenich, M. M., & Nahum, M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0510-1 · Cited by 33
Virtual Environments Using Video Capture for Social Phobia with Psychosis
Gega, L., White, R. T., Clarke, T., Turner, R., & Fowler, D. G. (2013) · Cyberpsychology Behavior and Social Networking · doi:10.1089/cyber.2013.1510 · Cited by 33
Olfactory impairment in first-episode schizophrenia: a case-control study, and sex dimorphism in the relationship between olfactory impairment and psychotic symptoms
Chen, X., Xu, J., Li, B., Guo, W., Zhang, J., & Hu, J. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1786-8 · Cited by 31
Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder
Tan, X. W., Seow, E., Abdin, E., Verma, S. K., Sim, K., Chong, S. A., & Subramaniam, M. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2248-7 · Cited by 30
The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial
Chen, L., Johnston, J. A., Kinon, B. J., Stauffer, V. L., Succop, P. S., Marques, T. R., & Ascher‐Svanum, H. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-320 · Cited by 30
Evaluation of the therapeutic effect of theta burst stimulation on drug-resistant auditory hallucinations in a schizophrenic patient and its impact on cognitive function and neuronal excitability: A case study
Sidhoumi, D., Braha, S., Bouaziz, N., Brunelin, J., Benadhira, R., & Januel, D. (2010) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.12.033 · Cited by 30
Association study of myelin transcription factor 1‐like polymorphisms with schizophrenia in Han Chinese population
Li, W., Wang, X., Zhao, J., Lin, J., Song, X., Yang, Y., Jiang, C., Xiao, B., Yang, G., Zhang, H. ‐., et al. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00734.x · Cited by 31
Prevalence of substance misuse among individuals with severe mental illness in S�o Paulo
Menezes, P. R., & Ratto, L. R. C. (2004) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-004-0730-z · Cited by 30
Elucidating the role of Early Maladaptive Schemas for psychotic symptomatology
Sundag, J., Ascone, L., Marques, A. D. M., Moritz, S., & Lincoln, T. M. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.02.008 · Cited by 32
Treatment Response to Olanzapine and Haloperidol and its Association with Dopamine D 2 Receptor Occupancy in First-Episode Psychosis
Zipursky, R. B., Christensen, B. K., Daskalakis, Z. J., Epstein, I., Roy, P., Furimsky, I., Sanger, T. M., & Kapur, S. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000806 · Cited by 30
A 1-Year Cost-Effectiveness Model for the Treatment of Chronic Schizophrenia with Acute Exacerbations in Belgium
Lecomte, P., Binder, M. D., van Dijk, M., Nuijten, M. J. C., Nuyts, G., & Persson, U. (2000) · Value in Health · doi:10.1046/j.1524-4733.2000.31001.x · Cited by 30
A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence
Alexander, P. D., Gicas, K. M., Willi, T. S., Kim, C. N., Boyeva, V., Procyshyn, R. M., Smith, G. N., Thornton, A. E., Panenka, W. J., Jones, A. A., et al. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4551-7 · Cited by 29
Sensory modulation and daily-life participation in people with schizophrenia
Lipskaya‐Velikovsky, L., Bar‐Shalita, T., & Bart, O. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.12.009 · Cited by 29
Schizophrenia and Bartonella spp. Infection: A Pilot Case–Control Study
Lashnits, E. W., Maggi, R. G., Jarskog, L. F., Bradley, J. M., Breitschwerdt, E. B., & Frӧhlich, F. (2021) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2020.2729 · Cited by 29
La SUMD (Scale to Assess Unawareness of Mental Disorder): Validation et adaptation française dans une population de patients souffrant de schizophrénie
Raffard, S., Trouillet, R., Capdevielle, D., Gély-Nargeot, M.-C., Bayard, S., Larøi, F., & Boulenger, J. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500807 · Cited by 29
Trauma and comorbid posttraumatic stress disorder in individuals with schizophrenia and substance abuse
Picken, A., & Tarrier, N. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.10.008 · Cited by 29
Duration of untreated illness in schizophrenia is not associated with 5-year brain volume change
Boonstra, G., Cahn, W., Schnack, H. G., Pol, H. E. H., Minderhoud, T. C., Kahn, R. S., & van Haren, N. E. M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.018 · Cited by 29
The importance of cross-sectional remission in schizophrenia for long-term outcome: A clinical prospective study
Helldin, L., Kane, J. M., Hjärthag, F., & Norlander, T. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.07.004 · Cited by 29
Choice of units of analysis and modeling strategies in multilevel hierarchical models
Abrahantes, J. C., Molenberghs, G., Burzykowski, T., Shkedy, Z., Alonso, A., & Renard, D. (2004) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2003.12.003 · Cited by 29
Association between Ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients
Yang, Y., Li, W., Zhao, J., Zhang, H., Song, X., Xiao, B., Ge, Y., Jiang, C., Zhang, D., Yue, W., et al. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-11 · Cited by 29
Monocausal attribution and its relationship with reasoning biases in schizophrenia
Moritz, S., Bentall, R. P., Kolbeck, K., & Roesch-Ely, D. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.06.057 · Cited by 28
Evidence that brain tissue volumes are associated with HVA reactivity to metabolic stress in schizophrenia
Marcelis, M. C., John Suckling, A., Hofman, P. A. M., Woodruff, P. W. R., Bullmore, E. T., & van Os, J. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.05.001 · Cited by 29
A Study of Polypharmacy with Second Generation Antipsychotics in Patients with Severe and Persistent Mental Illness
Megna, J. L., Kunwar, A., MAHLOTRA, K., Sauro, M. D., Devitt, P. J., & Rashid, A. (2007) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000265773.03756.3e · Cited by 28
Cost-utility of risperidone compared with standard conventional antipsychotics in chronic schizophrenia
OH, P. I., Lanctôt, K. L., Mittmann, N., Iskedjian, M., & Einarson, T. R. (2001) · Journal of Medical Economics · doi:10.3111/200104137156 · Cited by 28
Tobacco smoking in Egyptian schizophrenia patients with and without obsessive–compulsive symptoms
Fawzi, M. H., Fawzi, M. M., Khedr, H., & Fawzi, M. M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.06.005 · Cited by 27
Could PANSS be a useful tool in the determining of the stages of schizophrenia? A clinically operational approach
Dragioti, E., Wiklund, T., Siamouli, M., Moutou, K., & Fountoulakis, K. Ν. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.11.013 · Cited by 28
Impaired relational memory in the early stage of psychosis
Avery, S. N., Armstrong, K., Blackford, J. U., Woodward, N. D., Cohen, N. J., & Heckers, S. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.07.060 · Cited by 30
Motor-related oscillatory activity in schizophrenia according to phase of illness and clinical symptom severity
Gascoyne, L. E., Brookes, M. J., Rathnaiah, M., Katshu, M. Z. U. H., Koelewijn, L. C., Williams, G., Kumar, J., Walters, J., Seedat, Z. A., Palaniyappan, L. K., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102524 · Cited by 28
Trait Anhedonia in Schizophrenia: A Systematic Review and Comparative Meta-analysis
Krzyzanowski, D. J., Wu, S., Carnovale, M., Agarwal, S. M., Remington, G. J., & Goghari, V. M. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab136 · Cited by 30
Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Chinese-Han population
Li, W., Yang, Y., Lin, J., Wang, S., Zhao, J., Ge, Y., Wang, X., Ding, M., Zhang, H., & Lv, L. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.003 · Cited by 28
Attitude towards adherence in patients with schizophrenia at discharge
Schennach-Wolff, R., Jäger, M., Seemüller, F., Obermeier, M., Messer, T., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L., Gäebel, W., et al. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.05.003 · Cited by 28
Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis
Woodward, T. S., Jung, K., Smith, G. N., Hwang, H., Barr, A. M., Procyshyn, R. M., Flynn, S. W., van der Gaag, M., & Honer, W. G. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0460-x · Cited by 29
A framework for understanding experiential deficits in schizophrenia
Cohen, A. S., Minor, K. S., & Najolia, G. M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.11.016 · Cited by 28
Power spectrum scale invariance identifies prefrontal dysregulation in paranoid schizophrenia
Rǎdulescu, A., Rubin, D., Strey, H. H., & Mujica-Parodi, L. R. (2011) · Human Brain Mapping · doi:10.1002/hbm.21309 · Cited by 28
A Neuropsychological Study of Prefrontal Lobe Function in the Positive and Negative Subtypes of Schizophrenia
Mattson, D. T., Berk, M., & Lucas, M. (1997) · The Journal of Genetic Psychology · doi:10.1080/00221329709596685 · Cited by 28
Semantics, pragmatics, and formal thought disorders in people with schizophrenia
Salavera, C., Puyuelo, Antoñanzas, & Teruel (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s38676 · Cited by 28
Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: Comparing treatment with risperidone and haloperidol
Riedel, M. J., Mayr, A. J., Seemüller, F., Maier, W., Klingberg, S., Heuser, I., Klosterkötter, J., Gastpar, M., Schmitt, A., Sauer, H., et al. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.552633 · Cited by 28
Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia
Zhang, C., Wang, Q., Ni, P., Deng, W., Li, Y., Zhao, L., Ma, X., Wang, Y., Yu, H., Li, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10688-1 · Cited by 30
A comparison of instrument sensitivity to negative symptom change
Eckert, S. L., Diamond, P. M., Miller, A. L., Velligan, D. I., Funderburg, L. G., & True, J. E. (1996) · Psychiatry Research · doi:10.1016/0165-1781(96)02870-3 · Cited by 28
The Impact of Anticholinergic Burden on Functional Capacity in Persons With Schizophrenia Across the Adult Life Span
Khan, W. U., Ghazala, Z., Brooks, H. J., Subramaniam, P., Mulsant, B. H., Kumar, S., Voineskos, A. N., Blumberger, D. M., Kern, R. S., & Rajji, T. K. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa093 · Cited by 27
Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia
Pawełczyk, T., Szymańska, B., Grancow-Grabka, M., Kotlicka‐Antczak, M., & Pawełczyk, A. M. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s82468 · Cited by 27
EEG coherence following acute and chronic clozapine in treatment-resistant schizophrenics.
Knott, V., Labelle, A., Jones, B., & Mahoney, C. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.10.4.435 · Cited by 27
Inhibition of return and schizophrenia: A meta-analysis
Mushquash, A. R., Fawcett, J. M., & Klein, R. M. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.034 · Cited by 27
Does Clinical Judgment of Baseline Severity and Changes in Psychopathology Depend on the Patient Population?
Schennach-Wolff, R., Obermeier, M., Seemüller, F., Jäger, M., Schmauß, M., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L., Gäebel, W., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181faf39b · Cited by 27
Serum thiobarbituric acid-reactive substances and free thiol levels in schizophrenia patients: Effects of antipsychotic drugs
Huang, T., Liou, C., & Lin, T. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.01.017 · Cited by 27
Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset
Rey, R., d’Amato, T., Boyer, L., Brunel, L., Aouizerate, B., Berna, F. S., Capdevielle, D., Chéreau, I., Chesnoy-Servanin, G., Denizot, H., et al. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0779-9 · Cited by 26
Quality of life for patients with schizophrenia in a Japanese psychiatric hospital
Kugo, A., Terada, S., Ishizu, H., Takeda, T., Sato, S., Habara, T., Fujimoto, Y., Namba, T., Horii, S., & Kuroda, S. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.06.012 · Cited by 27
Testing Liddle's three-syndrome model in families with schizophrenia
Bassett, A. S., Bury, A. S., & Honer, W. G. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90031-0 · Cited by 27
Risperidone: Review and Assessment of Its Role in the Treatment of Schizophrenia
Cardoni, A. A. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502900611 · Cited by 27
A Rating Scale for Psychotic Symptoms (RSPS)
Chouinard, G., & Miller, R. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00012-2 · Cited by 26
Predicting the future in schizophrenia: The discrepancy between anticipatory and consummatory pleasure
Edwards, C., Cella, M., Tarrier, N., & Wykes, T. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.091 · Cited by 26
Outcome of suicidal patients with schizophrenia: results from a naturalistic study
Schennach-Wolff, R., Jäger, M., Seemüller, F., Obermeier, M., Schmauß, M., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L., Gäebel, W., et al. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01484.x · Cited by 28
On the use of the Positive and Negative Syndrome Scale in randomized clinical trials
Nicotra, E. F., Casu, G., Piras, S., & Marchese, G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.04.006 · Cited by 26
Gender differences in schizophrenia: A multicentric study from three Latin-America countries
Caqueo‐Urízar, A., Fond, G. B., Alfonso Urzúa, M., & Boyer, L. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.05.032 · Cited by 26
Associations between P3a and P3b amplitudes and cognition in antipsychotic-naïve first-episode schizophrenia patients
Kruiper, C., Fagerlund, B., Nielsen, M. Ø., Düring, S. W., Jensen, M. H., Ebdrup, B. H., Glenthoj, B. Y., & Oranje, B. (2018) · Psychological Medicine · doi:10.1017/s0033291718001575 · Cited by 27
Ziprasidone as an adjuvant for clozapine‐ or olanzapine‐associated medical morbidity in chronic schizophrenia
Henderson, D. C., Fan, X., Copeland, P. M., Sharma, B., Borba, C. P. C., Forstbauer, S., Miley, K. M., Boxill, R., Freudenreich, O., Cather, C., et al. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1012 · Cited by 26
Dynamics of Self-Esteem in “Poor-Me” and “Bad-Me” Paranoia
Udachina, A., Varese, F., Oorschot, M., Myin‐Germeys, I., & Bentall, R. P. (2012) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e318266ba57 · Cited by 26

Authors: Kay, S. R., Opler, L. A., & Lindenmayer, J.-P.
Affiliations: Albert Einstein College of Medicine (US)
ORCID: Opler, Lewis A.
Lindenmayer, Jean-Pierre
Venue: Psychiatry Research
Publisher: Elsevier BV
Published: 1988-01
Volume: 23
Issue: 1
Pages: 99-110
ISSN: 0165-1781 (ISSN-L)
DOI: 10.1016/0165-1781(88)90038-8
OpenAlex: W2100828552
Cited by: 1,007
References: 28
Citations by year: 2026: 16 · 2025: 30 · 2024: 38 · 2023: 28 · 2022: 33 · 2021: 43 · 2020: 33 · 2019: 37 · 2018: 41 · 2017: 33 · 2016: 45 · 2015: 49 · 2014: 37 · 2013: 40 · 2012: 44
FWCI: 8.23
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Psychiatry Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Keywords: PANSS, schizophrenia, psychometric properties, inter-rater reliability, criterion validity, construct validity, positive symptoms, negative symptoms, cross-validation
MeSH terms: Adult, Female, Humans, Male, Prognosis, Psychiatric Status Rating Scales, Psychometrics, Schizophrenia, Schizophrenic Psychology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks